Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2024-06-07 00:00:00 ET · period of report 2024-06-05 · accession 0001415889-24-016064 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-07 | 2024-06-05 | MIRM | Ramasastry Saira | Dir | M - OptEx | $14.12 | +5,000 | 5,000 | New | +$70.6K |
| D | 2024-06-07 | 2024-06-05 | MIRM | Ramasastry Saira | Dir | S - Sale+OE | $25.68 | -5,000 | 0 | -100% | -$128.4K |
| DM | 2024-06-07 | 2024-06-05 | MIRM | Ramasastry Saira | Dir | A - Grant | $0.00 | +14.5K | 8,779 | New | $0 |
| D | 2024-06-07 | 2024-06-05 | MIRM | Ramasastry Saira | Dir | M - OptEx | $0.00 | -5,000 | 2,500 | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-05 | M | A | 5,000 | $14.12 | 5,000 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-05 | S | D | 5,000 | $25.68 | 0 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-06-05 | A | A | 5,703 | $0.00 | 5,703 | D | — · — to — | 5,703 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting. |
| 4 | Derivative | Stock Option (right to buy) | 2024-06-05 | M | D | 5,000 | $0.00 | 2,500 | D | $14.12 · 2022-05-31 to 2031-08-15 | 5,000 Common Stock | |
| 5 | Derivative | Stock Option (right to buy) | 2024-06-05 | A | A | 8,779 | $0.00 | 8,779 | D | $26.30 · — to 2034-06-04 | 8,779 Common Stock | (F1) The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2025 annual stockholder meeting. |